Polynucleotides encoding an actriib antibody
Granted 2 Aug 2016 · 4 office actions
Current assignee: Acceleron Pharma Inc. · originally DYAX CORP.
Law firm: Law firm · Log in to unlock
Attorney: Attorney · Log in to unlock
Inventors: Diana Martik, Janja Cosic, Ravindra Kumar, Asya Grinberg +3 · Examiner: Elly-Gerald Stoica · AU 1647 · TC 1600
Life of the patent
3 dated eventsAbstract
The disclosure provides, among other aspects, neutralizing antibodies and portions thereof that bind to ActRIIB and uses for same.
Claims
4 · 1 independent · depth 4Classifications
3 codes- A61K31/711
- C07K16/28
- C07K16/40
Claim changes
SoonSee which claims were amended, added or cancelled during examination, with every added and removed word marked.
The published claims of this patent are not paired with the granted ones in what we hold.
File wrapper
See the full prosecution history — every USPTO and applicant action on this file, in order.
Log in to unlockTerm & fees
See the term timeline — pendency span, in-force span, the maintenance fees paid and both computed expiry dates.
Log in to unlockPriority chain
1 priority documents›Priority documents — 1
| Type | Document | Date |
|---|---|---|
| related publication | US 20130189269 A1 | 25 Jul 2013 |
Validity challenges
See the validity challenges on record — reexaminations, IPRs and PGRs, with their institution decisions and outcomes.
Log in to unlockCitations
See every patent this one cites and every patent that cites it back — publication, assignee, and how each one was found.
Log in to unlock